Insight Molecular Diagnostics (IMDX) Other Non Operating Income (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Other Non Operating Income of $146000.0 for Q1 2026, down 71.15% sequentially from $506000.0 in Q4 2025, and down 7.01% YoY from $157000.0 in Q1 2025.
Insight Molecular Diagnostics (IMDX) Other Non Operating Income (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics has reported Other Non Operating Income for 12 years, with the latest figure at $146000.0 in Q1 2026.
- Quarterly Other Non Operating Income fell 7.01% year-over-year to $146000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 25100.0% YoY) and the FY2025 annual result came in at $1.0 million, up 12737.5% from the prior year.
- Other Non Operating Income fell to $146000.0 in Q1 2026 per IMDX's latest filing, from $506000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $506000.0 in Q4 2025 and troughed at -$371000.0 in Q4 2022.
- A 5-year average of $86823.5 and a median of $125000.0 in 2025 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income plunged 1900.0% in 2022, then jumped 15400.0% in 2024.
- Over 5 years, Other Non Operating Income stood at -$371000.0 in 2022, then surged by 172.51% to $269000.0 in 2023, then sank by 220.45% to -$324000.0 in 2024, then surged by 256.17% to $506000.0 in 2025, then tumbled by 71.15% to $146000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $146000.0, $506000.0, and $223000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Insight Molecular Diagnostics | 172.94 Mn | 144.01 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 146,000.00 |
| Dec 31, 2025 | 506,000.00 |
| Sep 30, 2025 | 223,000.00 |
| Jun 30, 2025 | 125,000.00 |
| Mar 31, 2025 | 157,000.00 |
| Dec 31, 2024 | -324,000.00 |
| Sep 30, 2024 | 53,000.00 |
| Jun 30, 2024 | 110,000.00 |
| Mar 31, 2024 | 153,000.00 |
| Dec 31, 2023 | 269,000.00 |
| Sep 30, 2023 | 127,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | -371,000.00 |
| Sep 30, 2022 | 62,000.00 |
| Jun 30, 2022 | 278,000.00 |
| Mar 31, 2022 | -36,000.00 |
| Sep 30, 2021 | -8,000.00 |
| Jun 30, 2021 | 16,000.00 |
| Mar 31, 2021 | 2,000.00 |